Recombinant Humanized monoclonal antibody expressed in CHO binding to Human CD276. This antibody is a first-in-class, humanized IgG1κ monoclonal antibody that recognizes human B7-H3, a novel member of the B7 family of immune regulators. This antibody has been Fc-engineered to further augment its tumor killing activity.
Figure 1 CD276 Recombinant Antibody (TAB-117CL) in SDS-PAGE
SDS-PAGE analysis of TAB-117CL in non-reduced (Lane 1) and β-mercaptoethanol-reduced (Lane 2) conditions.
Figure 2 CD276 Recombinant Antibody (TAB-117CL) in HPLC
The purity of TAB-117CL was greater than 95% as determined by SEC-HPLC.
This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:
• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production
See more details about Hi-Affi™ recombinant antibody benefits.
Download resources about recombinant antibody development and antibody engineering to boost your research.
Select a product category from the dropdown menu below to view related products.
CAT | Product Name | Application | Type |
---|---|---|---|
NEUT-333CQ | Rat Anti-CD276 Recombinant Antibody (clone MJ18) | Block, FC | Rat IgG1 |
There are currently no Customer reviews or questions for TAB-117CL. Click the button above to contact us or submit your feedback about this product.
To accurately reference this product in your publication, please use the following citation information:
(Creative Biolabs Cat# TAB-117CL, RRID: AB_3111822)
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.